Dupilumab as a novel treatment option for prurigo nodularis

被引：2
|
作者：
Nakajima, Saeko [1 ,2 ]
Yonekura, Satoru [1 ]
Nakamizo, Satoshi [1 ,3 ]
Egawa, Gyohei [1 ]
Kabashima, Kenji [1 ,4 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Dermatol, 54 Shogoin Kawahara, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Drug Discovery Inflammatory Skin Dis, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Med, Alliance Lab Adv Med Res, Kyoto, Japan
[4] Agcy Sci Technol & Res, A STAR Skin Res Labs, Singapore, Singapore
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2023年 / 152卷 / 04期
关键词：
Prurigo nodularis; dupilumab; type; 2; inflammation; ITCH;
D O I：
10.1016/j.jaci.2023.08.011
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：870 / 872
页数：3
相关论文
共 50 条
  • [1] Dupilumab treatment of prurigo nodularis in an adolescent
    Giovannini, Mattia
    Mori, Francesca
    Oranges, Teresa
    Ricci, Silvia
    Barni, Simona
    Canessa, Clementina
    Liccioli, Giulia
    Lodi, Lorenzo
    Sarti, Lucrezia
    Novembre, Elio
    Azzari, Chiara
    Filippeschi, Cesare
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (01) : 104 - 106
  • [2] Emerging treatment of prurigo nodularis with dupilumab
    Humpel, Olivia
    Fill, Lauren
    Hostoffer, Robert
    [J]. JOURNAL OF OSTEOPATHIC MEDICINE, 2023, 123 (11): : 555 - 556
  • [3] Dupilumab treatment of prurigo nodularis in an adolescent
    Mattia Giovannini
    Francesca Mori
    Teresa Oranges
    Silvia Ricci
    Simona Barni
    Clementina Canessa
    Giulia Liccioli
    Lorenzo Lodi
    Lucrezia Sarti
    Elio Novembre
    Chiara Azzari
    Cesare Filippeschi
    [J]. European Journal of Dermatology, 2021, 31 : 104 - 106
  • [4] Dupilumab Treatment for Prurigo Nodularis and Pruritis
    Tanis, Ross
    Ferenczi, Katalin
    Payette, Michael
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (09) : 940 - 942
  • [5] Dupilumab Treatment for Generalized Prurigo Nodularis
    Beck, Kristen M.
    Yang, Eric J.
    Sekhon, Sahil
    Bhutani, Tina
    Liao, Wilson
    [J]. JAMA DERMATOLOGY, 2019, 155 (01) : 118 - 120
  • [6] Dupilumab as a useful treatment option for prurigo nodularis in an elderly patient with atopic diathesis
    Criado, Paulo R.
    Pincelli, Thais P.
    Criado, Roberta F. J.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E358 - E361
  • [7] Dupilumab for treatment-refractory prurigo nodularis
    Kovacs, Balint
    Rose, Ellen
    Kuznik, Nadine
    Shimanovich, Iakov
    Zillikens, Detlef
    Ludwig, Ralf J.
    Thaci, Diamant
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 (06):
  • [8] Dupilumab for the treatment of prurigo nodularis: A systematic review
    Cao, Peng
    Xu, Wenjing
    Jiang, Shuyi
    Zhang, Litao
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [9] Dupilumab as promising treatment for prurigo nodularis: current evidences
    Toffoli, Ludovica
    Farinazzo, Eleonora
    Zelin, Enrico
    Agozzino, Marina
    Dianzani, Caterina
    Di Meo, Nicola
    Nan, Katiuscia
    Zalaudek, Iris
    Conforti, Claudio
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1306 - 1311
  • [10] Dupilumab: A Safe and Successful Treatment in Refractory Prurigo Nodularis
    Cunha, Ines Machado
    Valadao, Ivone
    Gomes, Eva
    Marinho, Antonio
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1365 - 1366
12345